DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares NASDAQ Listed Jan 27, 2025$10.60
Mkt Cap $357.4M
52w Low $10.09
99.8% of range
52w High $10.60
50d MA $10.51
200d MA $10.37
P/E (TTM)
55.6x
EV/EBITDA
-77.4x
P/B
0.9x
Debt/Equity
0.0x
ROE
-81.8%
P/FCF
-404.0x
RSI (14)
—
ATR (14)
—
Beta
-0.00
50d MA
$10.51
200d MA
$10.37
Avg Volume
159.2K
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
1 East Broward Blvd Suite 700 · Fort Lauderdale, FL 33301 · US
Data updated apr 25, 2026 5:26am
· Source: massive.com